Sign in
8-K

Current Report

MiNK Therapeutics, Inc. Filed Acc 0001193125-25-009595

Bylaws or fiscal year change · Shareholder vote results

  • Item 5.03 Amendments to articles or bylaws; change in fiscal year
  • Item 5.07 Submission of matters to a vote of security holders

From the SEC's structured data for this filing

Loading d926991d8k.htm…